secwatch.observer — SEC 8-K summary
======================================

Issuer:     LianBio (LIANY)
CIK:        0001831283
Form:       8-K
Filed at:   2022-12-13T23:59:59+00:00
Accession:  0001831283-22-000079
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LianBio President and Chief Strategy Officer Debra Yu resigns effective Jan 1, 2023
--------------------------------------------------------------------------------

- Debra Yu, President and CSO, resigns effective Jan 1, 2023 to pursue other business opportunities.
- Yu entered a consulting agreement with LianBio from Jan 1 to June 30, 2023 to facilitate transition.
- Separation agreement includes 12 months base salary, 14-month lump sum, and extended option exercisability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831283/000183128322000079/0001831283-22-000079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831283/000183128322000079/lian-20221209.htm
  HTML page:      https://secwatch.observer/filing/0001831283-22-000079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer